Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 745-754 of 1965


California's $70 Million Alpha Stem Cell Clinic Plan Edging Forward by David JensenCalifornia Stem Cell ReportSeptember 30th, 2013The California stem cell agency predicts that “human healthcare will be greatly improved” by stem cell research by 2024 and is fleshing out an ambitious plan to help make that happen.
When Will Gene Therapy Come to the U.S.?by Susan YoungMIT Technology ReviewSeptember 30th, 2013Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
Blinded By Science[Mentions CGS's Jessica Cussins]Center for Environmental HealthSeptember 30th, 2013Three stories of science gone wrong: distorted science, unethical science, and just plain nutty science. We learn about geoengineering, flame retardant chemicals, and the controversy over misuse of Havasupai DNA.
Your Body, Their Propertyby Osagie K. ObasogieBoston ReviewSeptember 30th, 2013When the U.S. Supreme Court struck down human gene patents it took one aspect of the debate over property interests in human biological materials off the table. But other body parts are still considered fair game.
Scientists Warn Against “Three-Parent IVF” Experimentby Jessica CussinsBiopolitical TimesSeptember 25th, 2013Three evolutionary biologists enumerate a number of scientific studies and methodological shortcomings that have been overlooked in the debate on mitochondrial replacement. Their study has elicited numerous defensive responses, despite bringing important details to bear.
On Designer Babiesby Sheldon KrimskyTufts Medicine, Summer 2013It is unimaginable that any humane society would permit a human trial of genetic modification where the potential risks so outweigh the social benefits.
Unlicensed Doctor who 'Sold Hope to Patients who had None' Sentencedby Jeff GermanLas Vegas Review-JournalSeptember 24th, 2013An unlicensed physician described as a "modern-day Dr. Frankenstein" was sentenced to federal prison for defrauding chronically ill patients through a phony stem cell implant procedure.
At the End of the Slippery Slope: Margaret Atwood’s MaddAddam Trilogyby George Estreich, Biopolitical Times guest contributorSeptember 24th, 2013Atwood says her trilogy "invents nothing we haven’t already invented or started to invent" — suggesting that though her work is fiction and not a tract, she also intends to do far more than entertain.
Gene Therapy With a Differenceby Andrew PollackThe New York TimesSeptember 23rd, 2013The idea is that a disease can be ameliorated not by replacing a defective gene, as is done in gene therapy, but by correcting it. But hopes for the new technique have now suffered a big blow.
More DNA Samples, More Debateby Erica E. PhillipsThe Wall Street JournalSeptember 23rd, 2013In Orange County, California, officials are taking DNA samples from people charged with minor offenses such as shoplifting and drug possession, in exchange for agreeing to dismiss the charges or as part of plea deals.
Displaying 745-754 of 1965  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760